Vasopressin Completed Phase 3 Trials for Shock, Septic Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01718613Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients